Tesla (TSLA.US) shares gained more than 5.5% on Monday, breaking a six-session streak of declines after brokerage Baird Equity Research added Tesla shares to its 'best ideas' list.
The financial institution backed up its decision with a communiqué in which analysts recognise that price cuts and their impact on margins will drive the narrative around the company in the second half of the year, but for interest in the company to develop to its full potential, other factors will need to be met, such as the launch of production and sales of Cybertruck cars, wider adoption of fully autonomous driving and expansion into new markets.
As a reminder, the company has already added more than 85% this year on a wave of rising sales.
The company's shares stopped the wave of declines on the weekly interval in the support zone defined by the 50-week EMA and the 100-week EMA (blue and purple curves respectively). Source: xStation 5
Stock of the Week AMD: From second choice to core pillar of the AI infrastructure
US OPEN: Wall Street opens higher ๐ผ Datadog and ARM in the spotlight ๐ฅ
Rheinmetall earninigs: Weak sales overshadow strong prospects
ARM Holdings Moves Closer to the Center of the AI Revolution. Strong Results Are No Longer Enough for the Market
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
